28 Oct 2020 | 10:31 am | 1 min. read
Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.
4D, who are leading the development of live biotherapeutic products, are believed to be the first UK biotech to make the move to NASDAQ via the acquisition of a SPAC, breaking new ground for UK listed biotechs. The Company will also maintain its current listing on AIM.
With 4D acquiring the SPAC in order to inherit its listing on NASDAQ, they are able to by-pass the usual nine month lead-in time foreign issuers have to contend with when seeking a direct listing on NASDAQ.
The Pinsent Masons team was led by Charles Waddell and Sunjay Malhotra with assistance from Julian Stanier, Amy Moore and Nathalie Goetsches; US securities advice was provided by Roberta Markovina and Beatrice Kelly; Eloise Walker, Jamie Robson and Daniel Place assisted on UK tax matters; and Fleur Benns and James Sullivan-Tailyour provided assistance with regards to 4D’s share option plans.
Commenting on the transaction, lead partner at Pinsent Masons Charles Waddell said:
"We have enjoyed working with 4D for a number of years, they are at the cutting edge of live biotherapeutic products and this transaction is an important step in their future development and access to key to international markets.
Given the number of European biotechs that covet a move to NASDAQ, and notwithstanding the complex financing structures of SPACs, this deal highlights that there is an alternative route to the US markets. It is therefore unlikely to be the last biotech we see looking at SPACs to access the deep pool of sophisticated investors in the US."
Pinsent Masons has advised Q ENERGY on the design and drafting of a refurbishment contract for an innovative wind project in France, relying exclusively on second-hand wind turbines. The project, scheduled for commissioning in 2028, represents a significant step forward in the integration of circular‑economy principles within the renewable energy sector.
Multinational law firm Pinsent Masons has strengthened its international arbitration practice with the appointment of Cem Kalelioglu as a partner in London, reinforcing the firm's growing presence in high-value investor-state and commercial disputes.
Multinational law firm Pinsent Masons has advised global wind turbine manufacturer Vestas on its role in the Delburn Wind Farm in the Australian state of Victoria.
Multinational law firm Pinsent Masons has advised on the sale of VLocker, a global leader in the design, manufacture, installation and management of electronic locker systems, to Venu+, a United States‑based portfolio company of private equity fund ZCG.
Multinational law firm Pinsent Masons has advised international cinema technology business INDY Cinema (INDY) on its acquisition by New York-based VERSANT, an industry-changing media and entertainment company.
Multinational law firm Pinsent Masons has advised Southeast Asia-based clean energy developer Alba Renewables on its acquisition by a leading global investment firm.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]
